{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:34Z","timestamp":1783075894700,"version":"3.54.6"},"reference-count":19,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1111\/jcpt.12286","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T13:37:49Z","timestamp":1432647469000},"page":"480-482","source":"Crossref","is-referenced-by-count":8,"title":["Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine"],"prefix":"10.1155","volume":"40","author":[{"given":"Y.","family":"Akamine","sequence":"first","affiliation":[{"name":"Department of Pharmacy; Akita University Hospital; Akita Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy; Faculty of Medicine; University of the Ryukyus; Okinawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Akita University Hospital; Akita Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yasui-Furukori","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry; Hirosaki University School of Medicine; Hirosaki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Zikeikai-Aoimori Hospital; Aomori Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"key":"10.1111\/jcpt.12286-BIB0001|jcpt12286-cit-0001","unstructured":"Guidance for Industry Drug Interaction Studies 2012 http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM292362.pdf"},{"key":"10.1111\/jcpt.12286-BIB0002|jcpt12286-cit-0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/17425250903379546","article-title":"The missing linkage: what pharmacogenetic associations are left to find in CYP3A?","volume":"6","author":"Perera","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/jcpt.12286-BIB0003|jcpt12286-cit-0003","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0731-7085(98)00261-1","article-title":"Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia","volume":"19","author":"Nagasaki","year":"1999","journal-title":"J Pharm Biomed Anal"},{"key":"10.1111\/jcpt.12286-BIB0004|jcpt12286-cit-0004","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jpba.2007.11.006","article-title":"Simultaneous determination of metoprolol succinate and amlodipine besylate in pharmaceutical dosage form by HPLC","volume":"46","author":"Dongre","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"10.1111\/jcpt.12286-BIB0005|jcpt12286-cit-0005","first-page":"295","article-title":"Simultaneous high performance liquid-chromatographic determination of carbamazepine, carbamazepine-10,11-epoxide, ethosuximide, phenobarbital, phenytoin, primidone and phenylethylmalonamide in plasma","volume":"21","author":"Neels","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1111\/jcpt.12286-BIB0006|jcpt12286-cit-0006","volume-title":"Product information: INVEGA","author":"Janssen Pharmaceutical K.K","year":"2011"},{"key":"10.1111\/jcpt.12286-BIB0007|jcpt12286-cit-0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1111\/jcpt.12286-BIB0008|jcpt12286-cit-0008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2133\/dmpk.DMPK-13-RG-127","article-title":"ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysis","volume":"29","author":"Zuo","year":"2014","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1111\/jcpt.12286-BIB0009|jcpt12286-cit-0009","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/dmd.113.055400","article-title":"Amlodipine metabolism in human liver microsomes and roles of CYP3A4\/5 in the dihydropyridine dehydrogenation","volume":"42","author":"Zhu","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/jcpt.12286-BIB0010|jcpt12286-cit-0010","first-page":"431","article-title":"Gateways to clinical trials","volume":"24","author":"Bay\u00e9s","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1111\/jcpt.12286-BIB0011|jcpt12286-cit-0011","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2165\/00003088-199121060-00005","article-title":"Pharmacokinetic interactions with calcium channel antagonists (Part II)","volume":"21","author":"Schlanz","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12286-BIB0012|jcpt12286-cit-0012","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clpt.2006.08.013","article-title":"Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine","volume":"80","author":"Oscarson","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12286-BIB0013|jcpt12286-cit-0013","first-page":"247","article-title":"The auto-induction of carbamazepine during long-term therapy","volume":"18","author":"Pynnonen","year":"1980","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1111\/jcpt.12286-BIB0014|jcpt12286-cit-0014","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cpt1978233320","article-title":"Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva","volume":"23","author":"Westenberg","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12286-BIB0015|jcpt12286-cit-0015","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1528-1167.2011.03140.x","article-title":"In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein","volume":"52","author":"Zhang","year":"2011","journal-title":"Epilepsia"},{"key":"10.1111\/jcpt.12286-BIB0016|jcpt12286-cit-0016","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1528-1167.2012.03409.x","article-title":"Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique","volume":"53","author":"Fortuna","year":"2012","journal-title":"Epilepsia"},{"key":"10.1111\/jcpt.12286-BIB0017|jcpt12286-cit-0017","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00003088-198510010-00004","article-title":"Carbamazepine metabolism in man. Induction and pharmacogenetic aspects","volume":"10","author":"Eichelbaum","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12286-BIB0018|jcpt12286-cit-0018","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clpt.2004.04.011","article-title":"Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol\u00a0in humans","volume":"76","author":"Giessmann","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12286-BIB0019|jcpt12286-cit-0019","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2125.2011.04106.x","article-title":"Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers","volume":"73","author":"Akamine","year":"2012","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12286","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12286","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12286\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:57Z","timestamp":1671818757000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12286","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}